Skip to Main Content

LABU  Direxion Daily S&P Biotech Bull 3X…
Exchange-Traded Fund
NYSE Arca

Morningstar Summary

Ratings & Reports

  • Overall
    as of --
    Star Rating: 0Not Rated
    Out of -- funds
  • 3 Year
    Star Rating: 0Not Rated
    Out of -- funds
  • 5 Year
    Star Rating: 0Not Rated
    Out of -- funds
  • 10 Year
    Star Rating: 0Not Rated
    Out of -- funds

Historical Risk

  • Low
  • Below Average
  • Avg
  • Above Average
  • High

Historical Return

  • Low
  • Below Average
  • Avg
  • Above Average
  • High

Morningstar Style Box

Market Cap vs. Investment Style
Selected Values: Investment Style: Mid, Market Cap: Growth
Value
Blend
Growth
Large
Mid
Small

Price Movement of LABU

Chart for Price Movement
LABU is down -5.98% over the last 3 days.
Bid/Ask1$63.65 / $64.05
Open$70.34
Previous Close$71.00
Day Low/High
Last Price
$63.56  2% or $0.22 from its Day low
$63.34
$71.39
52 Week Range
Last Price
$63.56  19% or $9.51 from its 52 Week high
$21.94
6/27/2016
$73.07
6/26/2017
Price/Earnings--
Price/Cash Flow--
Price/Revenue8.46x

Fund Detail

as of 5/31/2017

Profile

Profile
Total Net Assets$267.9 M
Premium/Discount0.24%
Portfolio Turnover--
Total Holdings13
Fund TypeETF
Transaction FeeYes

Distributions and Yield

Distributions and Yield
Distribution Yield0.00%
Most Recent Dividend--
Previous Pay Date--
Ex-Date--
Distribution FrequencyQuarterly
SEC Yield--

Total Returns

as of 5/31/2017

Standardized Returns

Standardized Returns: Monthly
Description3 Month1 Year3 Year5 Year10 YearInception3 Month1 Year3 Year5 Year10 YearInception3 Month1 Year3 Year5 Year10 YearInception
LABU Market Price
58.65%141.76%-------32.20%-13.84%18.68%-------47.16%52.41%74.03%-------47.54%
LABU NAV
52.54%179.47%-------32.20%-13.80%19.09%-------47.58%52.78%73.47%-------47.96%
Trading--Leveraged Equity
Morningstar Category
------------3.07%15.53%20.57%18.63%6.36%--3.19%9.51%24.83%16.48%5.43%--
S&P 500
Index
4.46%17.81%9.80%15.24%7.25%10.62%2.57%17.47%10.14%15.42%6.94%10.60%6.07%17.17%10.37%13.30%7.51%10.59%
View Performance >

Top 5 Holdings

as of 5/31/2017
Top 5 Holdings
--Fidelity Institutional Go23.09%
--Fidelity Institutional Go13.61%
--Goldman Finl Sq Trsry Ins7.06%
XBIOpens Flyout Module that includes Quote information for linked symbolSPDR® S&P Biotech ETF4.20%
--S&P Biotechnology Select3.24%
Total
51.20%
More Holdings >

Top Sectors

as of 5/31/2017
Top SectorsTop Sectors
Sector% of Holdings
Healthcare100.00%
Industrials0.00%
Real Estate0.00%
Technology0.00%
Total100.00%
Sign in to see if you own shares.
Additional Trading Options
Fund Highlights
Fund Strategy
The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the S&P Biotechnology Select Industry Index ("index"). The fund, under normal circumstances, invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments that provide daily leveraged exposure to the index and/or exchange-traded funds ("ETFs") that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
Morningstar Category
These funds seek to generate returns equal to a fixed multiple of the short-term returns of an equity index. The compounding of short-term returns results in performance that does not correspond to those of investing in the index with external leverage. For example, a fund attempting to achieve 2 times the returns of a given index on a daily basis is unlikely to deliver anything like 2 times the index's returns over periods longer than one day. Many of these funds seek to generate a multiple of the daily or weekly return of the reference index. Trading funds are not considered suitable for a long-term investor and are designed to be used by active traders.
  • Inception Date
    05/28/2015
  • 1.09%
    Net Expense may include reimbursements or fee waivers, which may be voluntary or contractual and may expire. See prospectus for more details.
  • Gross Expense Ratio
    1.11%
  • Index Fund
    Yes
  • Leveraged Fund
    Yes
  • Socially Conscious
    No
  • Actively Managed
    No
  • Fund Family
Opens a modal dialogOpens a modal dialogOpen flyout contentOpens a new window